Endodontic Practice US provides endodontic continuing education and other valuable resources to help you build upon your expertise in endodontics. Our continuing education is updated regularly and accessible any time, from anywhere.
Purchase a subscription today!

Septodont Buys DLA from Dentsply in Brazil


Septodont is pleased to announce its acquisition of DLA (injectable dental anesthetic manufacturing plant) from Dentsply International, located in Catanduva, Sao Paulo, Brazil. The acquisition was done through its Brazilian affiliate, TDV. Septodont is currently the leading manufacturer of dental injectable anesthetics in the world, producing over 500 million dental injectable anesthetic cartridges annually.

“Our immediate goal is to provide all customers with a seamless integration period, meaning that things will remain business as usual for now. In the longer term we will invest in the site by upgrading the product offerings and capitalizing on the wonderful team that’s been established at the Catanduva site”, stated Paul Mondock, President of Septodont, Americas.

This acquisition is Septodont’s second in the Brazilian market. In 2014, Septodont acquired the TDV organization based in Pomerode, Santa Caterina, Brazil and with this current investment, plans to strengthen their presence throughout the Latin American region and beyond.

“Brazil is obviously a growth market for Septodont. We are very excited and proud to be the new owners of such a fantastic facility and look forward to the many opportunities that this plant will provide us, not only in Brazil but globally”, stated Olivier Schiller, CEO of Septodont.


About Septodont:

Since its inception in 1932 by Annie & Nestor Schiller, Septodont has developed, manufactured and distributed a wide range of high quality products for dental professionals. Due to our long tradition of innovation and quality, we are at the forefront of the dental pharmaceutical industry. From local anesthetic cartridges, topical gels, dental needles, obturation powders & pastes to innovative restorative solutions, we can meet dentists needs in pain control, endodontics, restorative dentistry, infection control and more.

Today, the company employs over 1,400 people and owns manufacturing plants in the following countries: Brazil, France, US, Canada and India ; and is supported by an international distribution network that is dedicated to serving the needs of dental health professionals in more than 150 countries.

About DLA:

DLA Produces quality injectable dental anesthetics under the brands of Lidostesim® (Lidocaine), Mepivalem® (Mepivacaine) and Citanest® (Priolocaine)

Stay Relevant With Endodontic Practice US

Join our email list for CE courses and webinars, articles and more..

Scroll to Top